Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krishna J Rocha-Singh

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
JACC. Cardiovascular Interventions|May 16, 2020
Retrospective Real-World Studies of Paclitaxel and Mortality: Defining the Many Faces of BiasKrishna J Rocha-Singh
JACC. Cardiovascular Interventions|May 21, 2021
The Ranger "Low-Dose" Paclitaxel Drug-Coated Balloon: Is Less Really More?Krishna J Rocha-Singh
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 12, 2002
Combined glycoprotein IIb/IIIa receptor inhibition and low-dose fibrinolysis for peripheral arterial thrombosisKrishna J Rocha-Singh, Janiece Trokey
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 15, 2005
Glycoprotein IIb-IIIa receptor inhibition with eptifibatide in percutaneous intervention for symptomatic peripheral vascular disease: the circulate pilot trialKrishna J Rocha-Singh, Janiece Rutherford
JACC. Cardiovascular Interventions|December 21, 2019
Statistical Alchemy and the Road AheadKrishna J Rocha-Singh, Sue Duval
Journal of the American College of Cardiology|July 16, 2013
Renal sympathetic denervation for treatment-resistant hypertension…in moderationKrishna J Rocha-Singh, Richard E Katholi
Current Treatment Options in Cardiovascular Medicine|February 28, 2012
Endovascular therapy for vasculogenic erectile dysfunctionJason H Rogers, Krishna J Rocha-Singh
Evidence-Based Medicine|March 8, 2011
Catheter-based renal sympathetic denervation reduces systolic blood pressure by 32 mm Hg in people with treatment-resistant hypertensionRichard E Katholi, Krishna J Rocha-Singh
Progress in Cardiovascular Diseases|November 18, 2009
The role of renal sympathetic nerves in hypertension: has percutaneous renal denervation refocused attention on their clinical significance?Richard E Katholi, Krishna J Rocha-Singh
Journal of the American College of Cardiology|April 2, 2013
Reply: To PMID 23177300Jason H Rogers, Irwin Goldstein, Krishna J Rocha-Singh
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
JACC. Cardiovascular Interventions|May 16, 2020
Retrospective Real-World Studies of Paclitaxel and Mortality: Defining the Many Faces of BiasKrishna J Rocha-Singh
JACC. Cardiovascular Interventions|May 21, 2021
The Ranger "Low-Dose" Paclitaxel Drug-Coated Balloon: Is Less Really More?Krishna J Rocha-Singh
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 12, 2002
Combined glycoprotein IIb/IIIa receptor inhibition and low-dose fibrinolysis for peripheral arterial thrombosisKrishna J Rocha-Singh, Janiece Trokey
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 15, 2005
Glycoprotein IIb-IIIa receptor inhibition with eptifibatide in percutaneous intervention for symptomatic peripheral vascular disease: the circulate pilot trialKrishna J Rocha-Singh, Janiece Rutherford
JACC. Cardiovascular Interventions|December 21, 2019
Statistical Alchemy and the Road AheadKrishna J Rocha-Singh, Sue Duval
Journal of the American College of Cardiology|July 16, 2013
Renal sympathetic denervation for treatment-resistant hypertension…in moderationKrishna J Rocha-Singh, Richard E Katholi
Current Treatment Options in Cardiovascular Medicine|February 28, 2012
Endovascular therapy for vasculogenic erectile dysfunctionJason H Rogers, Krishna J Rocha-Singh
Evidence-Based Medicine|March 8, 2011
Catheter-based renal sympathetic denervation reduces systolic blood pressure by 32 mm Hg in people with treatment-resistant hypertensionRichard E Katholi, Krishna J Rocha-Singh
Progress in Cardiovascular Diseases|November 18, 2009
The role of renal sympathetic nerves in hypertension: has percutaneous renal denervation refocused attention on their clinical significance?Richard E Katholi, Krishna J Rocha-Singh
Journal of the American College of Cardiology|April 2, 2013
Reply: To PMID 23177300Jason H Rogers, Irwin Goldstein, Krishna J Rocha-Singh
Pageof 5